Balanced anesthesia with sevoflurane–fentanyl has been widely accepted as anesthetic management for neurosurgery. Propofol–remifentanil regimen has been successfully used in various surgical settings, but a comprehensive comparison of sevoflurane– fentanyl and propofol–remifentanil anesthesia in patients undergoing craniotomy for supratentorial intracranial surgery has not yet been done. The aim of this prospective, randomized, open-label clinical trial was to compare clinical properties of sevoflurane–fentanyl with propofol– remifentanil anesthesia in patients undergoing supratentorial intracranial surgery. The primary endpoint was to compare early postoperative recovery and cognitive functions within the two groups; we also evaluated hemodynamic events, vomiting, shivering, and pain. One hundred twenty patients (64 males; age 15–75 years) were randomized to either total intravenous anesthesia (group T) or sevoflurane anesthesia (group S). Emergence and extubation times and cognitive function (Short Orientation Memory Concentration Test [SOMCT]) were compared in the two groups. Brain swelling, incidence of hypotensive and hypertensive episodes, postoperative vomiting, shivering, and pain were also analyzed. The mean emergence time (12.2 6 4.9 minutes for group S versus 12.3 6 6.1 minutes for group T; P = 0.92) and extubation time (18.2 6 2.3 minutes for group S versus 18.3 6 2.1 minutes for group T; P = 0.80) were similar in the two groups. Average SOMCT scores, both 15 minutes after extubation (25.6 6 4.9 in group S versus 23.96 7.5 in group T; P = 0.14) and 45 minutes after extubation (27.3 6 2.2 in group S versus 26.0 6 5.1 in group T; P = 0.07) were also comparable. Brain swelling was present in seven and five patients in groups S and T, respectively (P = 0.76). Hypotension was present in 12% (group S) and 28% (group T) of patients (P = 0.02). Hypertension was present in 17% of patients in group S and 40% of patients in group T (P = 0.0046). Shivering was present in 18% and 25% of patients in groups T and S (P = 0.37). Our study demonstrates that there is no patient benefit of using total intravenous anesthesia with an ultra-short-acting opioid over the conventional balanced volatile technique in terms of recovery and cognitive functions.

NO DIFFERENCE IN EMERGENCE TIME AND EARLY COGNITIVE FUNCTION BETWEEN SEVOFLURANE-FENTANYL AND PROPOFOL.REMIFENTANYL IN PATIENTS UNDERGOING CRANIOTOMY FOR SUPRATENTORIAL INTRACRANIAL SURGERY / Magni, G; Baisi, F; LA ROSA, Italia; Imperiale, C; Fabbrini, V; Pennacchiotti, Ml; Rosa, Giovanni. - In: JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY. - ISSN 0898-4921. - STAMPA. - 17(3):(2005), pp. 134-138. [10.1097/01.ana.0000167447.33969.16]

NO DIFFERENCE IN EMERGENCE TIME AND EARLY COGNITIVE FUNCTION BETWEEN SEVOFLURANE-FENTANYL AND PROPOFOL.REMIFENTANYL IN PATIENTS UNDERGOING CRANIOTOMY FOR SUPRATENTORIAL INTRACRANIAL SURGERY.

LA ROSA, Italia;ROSA, Giovanni
2005

Abstract

Balanced anesthesia with sevoflurane–fentanyl has been widely accepted as anesthetic management for neurosurgery. Propofol–remifentanil regimen has been successfully used in various surgical settings, but a comprehensive comparison of sevoflurane– fentanyl and propofol–remifentanil anesthesia in patients undergoing craniotomy for supratentorial intracranial surgery has not yet been done. The aim of this prospective, randomized, open-label clinical trial was to compare clinical properties of sevoflurane–fentanyl with propofol– remifentanil anesthesia in patients undergoing supratentorial intracranial surgery. The primary endpoint was to compare early postoperative recovery and cognitive functions within the two groups; we also evaluated hemodynamic events, vomiting, shivering, and pain. One hundred twenty patients (64 males; age 15–75 years) were randomized to either total intravenous anesthesia (group T) or sevoflurane anesthesia (group S). Emergence and extubation times and cognitive function (Short Orientation Memory Concentration Test [SOMCT]) were compared in the two groups. Brain swelling, incidence of hypotensive and hypertensive episodes, postoperative vomiting, shivering, and pain were also analyzed. The mean emergence time (12.2 6 4.9 minutes for group S versus 12.3 6 6.1 minutes for group T; P = 0.92) and extubation time (18.2 6 2.3 minutes for group S versus 18.3 6 2.1 minutes for group T; P = 0.80) were similar in the two groups. Average SOMCT scores, both 15 minutes after extubation (25.6 6 4.9 in group S versus 23.96 7.5 in group T; P = 0.14) and 45 minutes after extubation (27.3 6 2.2 in group S versus 26.0 6 5.1 in group T; P = 0.07) were also comparable. Brain swelling was present in seven and five patients in groups S and T, respectively (P = 0.76). Hypotension was present in 12% (group S) and 28% (group T) of patients (P = 0.02). Hypertension was present in 17% of patients in group S and 40% of patients in group T (P = 0.0046). Shivering was present in 18% and 25% of patients in groups T and S (P = 0.37). Our study demonstrates that there is no patient benefit of using total intravenous anesthesia with an ultra-short-acting opioid over the conventional balanced volatile technique in terms of recovery and cognitive functions.
2005
01 Pubblicazione su rivista::01a Articolo in rivista
NO DIFFERENCE IN EMERGENCE TIME AND EARLY COGNITIVE FUNCTION BETWEEN SEVOFLURANE-FENTANYL AND PROPOFOL.REMIFENTANYL IN PATIENTS UNDERGOING CRANIOTOMY FOR SUPRATENTORIAL INTRACRANIAL SURGERY / Magni, G; Baisi, F; LA ROSA, Italia; Imperiale, C; Fabbrini, V; Pennacchiotti, Ml; Rosa, Giovanni. - In: JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY. - ISSN 0898-4921. - STAMPA. - 17(3):(2005), pp. 134-138. [10.1097/01.ana.0000167447.33969.16]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/240724
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 21
  • Scopus 93
  • ???jsp.display-item.citation.isi??? 75
social impact